Clinical Trial Update: Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry reports a Phase 1/2 study evaluating selinexor with ICE chemotherapy for B-cell non-Hodgkin lymphoma with secondary CNS involvemen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Central Nervous System Involvement By Lymphoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)
• Selinexor (selinexor)

Snippet

Sponsor: Samsung Medical Center | Conditions: B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory | Phase 1, Phase 2 | Status: RECRUITING